Tachyplesin

Tachyplesin I (TP-I) is an antimicrobial polypeptide originally detected in the leukocytes of Japanese Horse Shoe Crab. It has also been reported to inhibit the growth of gram positive bacteria, fungui and viruses suggesting its antimicrobial property.

The antimicrobial activity of the peptide is related to the composition of the pathogen membrane and ability of the peptide to permeabilize the cell membranes. Bacteria and fungi have negatively charged membranes, and the interaction of is mediated in large part by electrostatic interactions^[1] (you can see the Hydrophobic and Polar amino acids). Specifically, TP-I shows high affinity for lipopolysaccharides (LPS) of gram-negative bacteria, thus neutralizing its effects.

Structural highlights

Tachyplesine I is a 17-residue peptide containing six cationic residues with molecular weight - 2,269 and isoelectric point(pI) of 9.93. ^[2] The amino acid sequence of the TP-I is NH₂-Lys-Trp-Cys-Phe-Arg-Val-Cys-Tyr-Arg-Gly-Ile-Cys-Tyr-Arg-Arg-Cys-Arg-CONH₂.

The β-hairpin structure is well characterized by a β-turn for the centrally located residues Tyr-Arg-Gly-Ile.^[5]

Along with TP-I, there exists three linear derivatives: , TPF4 and TPA4 as shown below.

Image:Derivatives.jpg

Of those 3 linear derivatives of TP-I, TPA4 was inactive which was due to its incapability to form hairpin loop structure. This guided to the conclusion that linear Tachyplesin analogues do not show preferential affinity for LPS. Therefore, the hairpin properties of the peptide seems to be important for recognition of lipopolysaccharides and its biological activities.

TP-I undergoes confirmation change in . The backbone of the polypeptide becomes , making it more stable.

Mode of action

TP-I has affinity to LPS and also has ability to permeabilize the cell membrane of pathogens. Docking model suggests strong affinity to LPS gained by interaction between cationic residues of TP-I with phosphate group and sachharides of LPS. Furthermore, interaction between hydrophobic residues of TP-I with acyl chains of LPS strengthens the TP-I/LPS interaction. The binding of TPI to LPS neutralizes LPS, which is widely considered as endotoxin. In addition to LPS binding, footpriting analysis has revealed the binding of TP-I to DNA by interacting specifically in minor groove of DNA duplex. The interaction between TP-I and DNA is contributed by secondary structure of the peptide which contains an antiparallel beta-sheet constrained by two disulfide bridges and connected by β-turn.

Importance and relevance

Evidences suggest that TP-1 has ability to permeabilize the cell membranes of pathogens.^[1]. Also, LPS and DNA being the potential biological targets of the peptide, its antimicrobial activity might be exploited. Eyeing the potential of TP-1, it has been insetred successfully in genome of Ornithogalum dubium and Ornithogalum thyrsoides. These ornamentals plants were originally sensitive to soft rot erwinias (SREs) and insertion of TPI in the plants has successfully protected them without affecting their normal physiology.

A Cys Deleted Linear Analog

is a linear mutant lacking the cysteines and therfor also lacking the disulfide bonds (NH₂-Lys-Trp-Phe-Arg-Val-Tyr-Arg-Gly-Ile-Tyr-Arg-Arg-Arg-CONH₂). It contains a broad spectrum of bactericidal activity with a reduced hemolytic property that stems from selective interactions with the negatively charged lipids including LPS.

CDT demonstrated a marked inhibition of growth of Gram negative and Gram positive bacterial strains akin to TP-1.

Its MIC values were found to be lower agains E. Coli and Listeria monocytogenes in comperison to the native TP-1 peptide.

^[5]

Possible Function as antitumor peptide

The cationic nature of tachyplesin allows it to interact with anionic phospholipids present in the bacterial membrane and thereby disrupt membrane function.

The structural nature of Tachyplesin suggested that it might also posses antitumor properties. Since it can interact with the membrance of prokaryotic cell, it is likely that TP I can also interact with the mitochondrial membrane of eukaryotic cells due to the structure similarity of these membranes because mitochondria are widely belived to have evolved from prokaryotic cells that have established a symbiotic relationship with the promitive eukaryotic cell.

It was found that the synthetic RGD-Tachyplesin can inhibit the proliferation of TSU prostate cancer cells and B16 melanoma cells as well as endothelial cells in a dose-dependent mannar in vitro and reduce tumor growth in vivo by inducing apoptosis.^[2]